Total Funding
30
35
Total FundingSeries A raised
Growth Score
-4 pts
Heat Score
-5 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
121283
Interline Therapeutics is a drug discovery platform that enables the company to map and correct dysfunctional protein communities.
- Zach Sweeney: CEOPast Role: Denali Therapeutics, Chief Scientific Officer
David Tully: Vice President Medicinal Chemistry
About the Company
Interline Therapeutics is a drug discovery platform that enables the company to map and correct dysfunctional protein communities.
It uses genomics, proteomics, structural biology, and computational chemistry to map and modulate protein communities. Interline leverages recent advancements in these technologies, as well as collaborations with
leading academic groups, to develop a precision medicine platform focused on three essential areas, genomics, communities, and modulators.
The South San Francisco, California-located company was founded by Zach Sweeney in 2020.
